KMID : 0311120070480061020
|
|
Yonsei Medical Journal 2007 Volume.48 No. 6 p.1020 ~ p.1027
|
|
Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
|
|
Kim Sung-Wook
Jang Suk-Yong Jung Ki-Hoon Suh Jeong-Ill
|
|
Abstract
|
|
|
Purpose: It is known that cyclooxygenase (COX)-2 expression is increased in Barrett¡¯s esophagus and esophageal adenocarcinomas. We studied COX-2 expression and the effect sulindac has on the genesis of Barrett¡¯s esophagus and adenocarcinoma in rats undergoing esophagogastroduodenal anastomosis (EGDA).
Materials and Methods: Fifty-one rats were divided into a control group (n=27), a 500ppm sulindac-treated group (n=15) and 1000 ppm sulindac-treated group (n=9). Randomly selected rats were killed by diethyl ether inhalation at 20 and 40 weeks after surgery.
Results: At 40 weeks, rats treated with 1000 ppm sulindac showed narrower esophageal diameter and milder inflammation than the control rats. At 40 weeks, the incidence of Barrett¡¯s esophagus was similar between control and sulindac-treated groups, but the incidence of adenocarcinoma was significantly lower in the 1000ppm sulindac-treated group than either the control or 500 ppm sulindac-treated groups. COX-2 was significantly increased in the lower esophagus of control rats killed at 40 weeks. Cyclin D1 expression was negligible in the sulindac- treated group compared with the control group.
Conclusion: We suggest that the chemopreventive effect of sulindac is related to decreased COX-2 and cyclin D1 expression, which may be influenced by reduced inflammation
|
|
KEYWORD
|
|
Barrett¡¯s esophagus, esophageal adenocarcinoma, COX-2, sulindac
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|